Condition
Primary Open Angle Glaucoma or Ocular Hypertension clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Primary Open Angle Glaucoma or Ocular Hypertension clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Nigeria (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
SLT versus daily latanoprost to lower eye pressure in early to moderate open‑angle glaucoma and ocular hypertension
This trial will test whether a one‑time selective laser trabeculoplasty (SLT) or daily 0.005% latanoprost eye drops better lower eye pressure in treatment‑naïve adults with early to moderate primary open‑angle glaucoma or ocular hypertension.
-
Direct selective laser trabeculoplasty to lower eye pressure in untreated open-angle glaucoma
This study will try direct selective laser trabeculoplasty (DSLT) to lower eye pressure by more than 20% without glaucoma medications over six months in adults newly diagnosed with open-angle glaucoma or ocular hypertension.
Related topics
Quick answers
How many Primary Open Angle Glaucoma or Ocular Hypertension clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Nigeria (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.